Recent Updates
Recently added Catalysts
USNA Positive Sentiment

USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

Tuesday, July 14, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: USANA Health Sciences, Inc. has announced the release of its second quarter 2026 earnings results, which will be available after market close on August 4, 2026. Following the earnings release, a Management Commentary document will be posted on the company's Investor Relations website. Additionally, a conference call will be held to discuss the results with analysts.
Price reaction · baseline $21.4 (2026-07-14 close) · hit after-hours · clean, no other USNA news in the window
day 0 close · peak
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • USANA is actively engaging with investors through earnings announcements.
  • The scheduled conference call indicates transparency and communication.
  • The release of Management Commentary shows a commitment to providing insights.

Full Press Release Details

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2026 results will be released after the close of market on Tuesday, August 4, 2026. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and insti

Frequently Asked Questions

When will USANA release its Q2 2026 earnings?

USANA will release its Q2 2026 earnings after market close on August 4, 2026.

Where can I find USANA's Management Commentary?

The Management Commentary will be posted on USANA's Investor Relations website.

Will there be a conference call for the earnings release?

Yes, USANA will hold a conference call to discuss the earnings announcement.

ShareAdd on Google
Tags: USNA Viatris Investor Conferences Healthcare USANA earnings release conference call Investor Relations NYSE:USNA
Last updated: Jul 14, 2026

Biotech snapshot

Cash runway
$169M liquidity · $0M/mo burn
Low dilution risk